← Eichor
Condition: Advanced Solid Tumors With Mtap Gene Deletion Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Advanced Solid Tumors With Mtap Gene Deletion

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Assess Safety, Tolerability and Drug Levels of Navlimetostat (BMS-986504) in Participants With Advanced Solid
Phase 1 · 12 location(s) · Bristol-Myers Squibb · NCT07077434Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Phase 1/Phase 2 · 26 location(s) · Tango Therapeutics, Inc. · NCT05732831Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors
Phase 1/Phase 2 · 10 location(s) · InSilico Medicine Hong Kong Limited · NCT06414460Phase I Study of HSK41959 in Solid Tumors With MTAP Deletion
Phase 1 · 3 location(s) · Haisco Pharmaceutical Group Co., Ltd. · NCT06968572Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Phase 1 · 25 location(s) · Bristol-Myers Squibb · NCT05245500A Phase Ia/Ib Clinical Study of GH56 Capsules in Subjects With MTAP-Deleted Advanced Solid Tumors
Phase 1 · 4 location(s) · Suzhou Genhouse Bio Co., Ltd. · NCT06796699A Phase I Study of SY-9453 in Patients With Advanced Solid Tumors
Phase 1 · 1 location(s) · Shouyao Holdings (Beijing) Co. LTD · NCT07469982A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Phase 1 · 16 location(s) · IDEAYA Biosciences · NCT07277413A Study of PEP08 in Patients With MTAP-Del Advanced or Metastatic Solid Tumors
Phase 1 · 4 location(s) · PharmaEngine · NCT06973863A Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Partici
Phase 1 · 3 location(s) · Bristol-Myers Squibb · NCT06672523
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.